NEW ORLEANS, October 28, 2022 /PRNewswire/ — Kahn Swick & Foti, LLC (“KSF”) and KSF Associates, former Attorney General of Louisiana, Charles C. Foti, Jr.remind investors that they have up November 7, 2022 Filing of lead plaintiff’s motions in a securities class action lawsuit against Medtronic plc MDTif they bought the shares of the company between June 8, 2019and May 25, 2022, inclusive (the “Class Period”). This action is pending in The United States district court Minnesota.
What you can do
If you have purchased Medtronic stock and would like to discuss your legal rights and how this case may affect you and your right to compensation for your economic loss, you can contact KSF Managing Partner Lewis Kahn toll-free, without obligation and at no cost to you, at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nyse-mdt/ to learn more. If you wish to be a lead plaintiff in this class action lawsuit, you must file a petition with the court November 7, 2022.
About the lawsuit
Medtronic and certain of its officers are alleged to have failed to disclose material information during the Class Period in violation of federal securities laws.
On May 26, 2022The company released its fourth quarter and full fiscal year 2022 financial results and guidance for fiscal year 2023 and announced that due to the need to improve its quality control system and its expectation that the MiniMed 780G model – the Die Defendants had repeatedly identified as critical to future growth that the company would expect sales of its diabetes group to decline between 6% and 7% in fiscal 2023 if approval did not occur in 2023.
Medtronic shares fell on the news $6.10 per share, or nearly 6%, from a close of $105.54 per share May 25, 2022close $99.44 per share May 26, 2022.
The case is The Trustees of Local 464A Welfare and Pension Funds – Pension Fund, The Trustees of Local 464A United Food &…
